Multiply Labs, which develops robotic systems to automate pharmaceutical manufacturing processes, raised a $75M Series B led by Patrick Soon-Shiong's NantWorks (Maria Deutscher/SiliconANGLE)
Multiply Labs’ new round is aimed at scaling robots for the manufacturing bottleneck behind complex drugs.
The Series B totals $75 million and was led by Patrick Soon-Shiong’s NantWorks. Multiply Labs builds automation equipment for drugmakers, with the stated goal of narrowing the gap between drug discovery and drug manufacturing. Techmeme’s entry also points to coverage framing the company’s work around robotic production of complex medicines. Source: Techmeme's note
The Series B totals $75 million and was led by Patrick Soon-Shiong’s NantWorks. Multiply Labs builds automation equipment for drugmakers, with the stated goal of narrowing the gap between drug discovery and drug manufacturing. Techmeme’s entry also points to coverage framing the company’s work around robotic production of complex medicines. Source: Techmeme's note
score 6